Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection

ABSTRACT Infants are generally highly susceptible to oral pathogens. Intestinal infection and the associated diarrhea are significant global causes of morbidity and mortality in infants. Among the enteric pathogens, enteropathogenic Escherichia coli (EPEC) stands out as showing the highest risk for infection-induced death in infants ≤12 months old. We have developed an experimental model of infant infection with EPEC, using the mouse-specific pathogen Citrobacter rodentium. Our murine infant model is similar to EPEC infection in human infants since infant mice are much more susceptible to C. rodentium infection than adult mice; infants infected with 50-fold fewer bacteria than the standard adult dose uniformly succumbed to the infection. Infant infection is characterized by high early and sustained bacterial titers and profound intestinal inflammation associated with extensive necrosis and systemic dissemination of the bacteria. Therefore, it seems likely that infant deaths result from sepsis secondary to intestinal damage. Recently, specialized proresolving mediators (SPM) have been found to exert profound beneficial effects in adult models of infection. Thus, we investigated the actions of two proresolving lipid mediators, resolvin D1 (RvD1) and resolvin D5 (RvD5), on the course of infection in infants. Strikingly, postinfection treatment with RvD1 and RvD5 reduced bacterial loads, mitigated inflammation, and rescued the infants from death. Furthermore, postinfection treatment with RvD1 and RvD5 led to protection from reinfection associated with C. rodentium-specific IgG responses comparable to those in adults. These results indicate that SPM may provide novel therapeutic tools for the treatment of pathological intestinal infections in infants.

[1]  R. Furth,et al.  Characteristics and Functional Capacities of Human Cord Blood Granulocytes and Monocytes , 1984, Pediatric Research.

[2]  Ruth R. Montgomery,et al.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. , 2012, Immunity.

[3]  L. Norling,et al.  The resolution of inflammation: Principles and challenges. , 2015, Seminars in immunology.

[4]  W. Elias,et al.  Diarrheagenic Escherichia coli , 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[5]  C. Baker,et al.  Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci , 1991, Infection and immunity.

[6]  H. Abele,et al.  Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein‐labeled Escherichia coli and group B Streptococci , 2009, Cytometry. Part B, Clinical cytometry.

[7]  F. Bussière,et al.  Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL‐1β and TNFα released by inflammatory monocytes , 2016, Cellular microbiology.

[8]  B. Finlay,et al.  Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. , 2013, Trends in microbiology.

[9]  A. Davies,et al.  Minireview: clinical cryptosporidiosis. , 2010, Experimental parasitology.

[10]  L. Maródi.  Innate cellular immune responses in newborns. , 2006, Clinical immunology.

[11]  M. Hersberger,et al.  High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation , 2013, Lipids in Health and Disease.

[12]  D. Borenshtein,et al.  Utility of the Citrobacter rodentium infection model in laboratory mice , 2008, Current opinion in gastroenterology.

[13]  C. Poets,et al.  A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein‐labeled Escherichia coli: Comparison of cord blood macrophages and peripheral blood macrophages of healthy adults , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[14]  T. Schmidt,et al.  Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens , 2017, Science.

[15]  P. Sansonetti,et al.  Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis , 1994, The Journal of experimental medicine.

[16]  C. Serhan,et al.  Human Milk Proresolving Mediators Stimulate Resolution of Acute Inflammation , 2015, Mucosal Immunology.

[17]  L. Bry,et al.  THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM. , 2011, European journal of microbiology & immunology.

[18]  S. Ygberg,et al.  The developing immune system – from foetus to toddler , 2012, Acta paediatrica.

[19]  J. Filep,et al.  Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.

[20]  X. de la Rosa,et al.  Novel Resolvin D2 Receptor Axis in Infectious Inflammation , 2017, The Journal of Immunology.

[21]  C. Serhan,et al.  The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.

[22]  E. De Gregorio,et al.  MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life , 2015, The Journal of Immunology.

[23]  Gabriel Núñez,et al.  Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.

[24]  J. Takeda,et al.  The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury , 2009, The Journal of Immunology.

[25]  C. Siegrist,et al.  B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.

[26]  G. Shan,et al.  Etiology of Childhood Infectious Diarrhea in a Developed Region of China: Compared to Childhood Diarrhea in a Developing Region and Adult Diarrhea in a Developed Region , 2015, PloS one.

[27]  Derek W. Gilroy,et al.  Resolution of inflammation: a new therapeutic frontier , 2016, Nature Reviews Drug Discovery.

[28]  H. Kitazawa,et al.  Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection , 2016, Front. Immunol..

[29]  F. Bäckhed,et al.  Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice , 2016, PLoS pathogens.

[30]  M. Gareau,et al.  Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. , 2012, The Journal of infectious diseases.

[31]  D. Gilroy,et al.  New insights into the resolution of inflammation. , 2015, Seminars in immunology.

[32]  M. Pichichero,et al.  Immune responses in neonates , 2014, Expert review of clinical immunology.

[33]  B. Finlay,et al.  Clearance of Citrobacter rodentium Requires B Cells but Not Secretory Immunoglobulin A (IgA) or IgM Antibodies , 2004, Infection and Immunity.

[34]  J. Blanco,et al.  Virulence Markers of Enteroaggregative Escherichia coli Isolated from Children and Adults with Diarrhea in Brasília, Brazil , 2003, Journal of Clinical Microbiology.

[35]  Naveen Surendran,et al.  Neonatal Vaccination: Challenges and Intervention Strategies , 2016, Neonatology.

[36]  K. Schesser,et al.  Murine Neonates Are Highly Resistant to Yersinia enterocolitica following Orogastric Exposure , 2007, Infection and Immunity.

[37]  T. O'Shea,et al.  Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. , 2011, Cytokine.

[38]  J. Schwarze,et al.  Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology , 2010, Clinical Microbiology Reviews.

[39]  Jean-Frederic Colombel,et al.  Adherent-invasive Escherichia coli in inflammatory bowel disease , 2007, Gut.

[40]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[41]  E. Mohr,et al.  Vaccination in early life: standing up to the challenges. , 2016, Current opinion in immunology.

[42]  V. Nizet,et al.  Alterations in neonatal neutrophil function attributable to increased immature forms. , 2016, Early human development.

[43]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[44]  A. Lapillonne,et al.  Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life , 2014, BMC Pediatrics.

[45]  Sheng-hua Wu,et al.  Efficacy and safety of 15(R/S)‐methyl‐lipoxin A4 in topical treatment of infantile eczema , 2013, The British journal of dermatology.

[46]  C. Serhan,et al.  Identification of resolvin D2 receptor mediating resolution of infections and organ protection , 2015, The Journal of experimental medicine.

[47]  A. Varvarigou,et al.  Phagocytic ability of neutrophils and monocytes in neonates , 2011, BMC pediatrics.

[48]  C. Reardon,et al.  Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. , 2010, The Journal of infectious diseases.

[49]  D. Gilroy,et al.  Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.

[50]  G. Dougan,et al.  Citrobacter rodentium of mice and man , 2005, Cellular microbiology.

[51]  A. Chang,et al.  Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? , 2016, Chest.

[52]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[53]  B. Levy,et al.  Specialized pro-resolving mediators: endogenous regulators of infection and inflammation , 2015, Nature Reviews Immunology.

[54]  C. Serhan,et al.  Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  G. Núñez,et al.  Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination. , 2015, Cell host & microbe.

[56]  C. Serhan,et al.  Resolvin D3 multi-level proresolving actions are host protective during infection. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.

[57]  K. Kim.  Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.

[58]  M. Perretti,et al.  Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.

[59]  L. Bry,et al.  Critical Role of T Cell-Dependent Serum Antibody, but Not the Gut-Associated Lymphoid Tissue, for Surviving Acute Mucosal Infection with Citrobacter rodentium, an Attaching and Effacing Pathogen 1 , 2004, The Journal of Immunology.

[60]  R. F. Ramig.  The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. , 1988, Microbial pathogenesis.

[61]  C. Serhan,et al.  Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance , 2016, Scientific Reports.

[62]  S. Savkovic,et al.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation , 2003, Gut.

[63]  B. Levy,et al.  Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation , 2015, Mucosal Immunology.

[64]  B. Finlay,et al.  Citrobacter rodentium: infection, inflammation and the microbiota , 2014, Nature Reviews Microbiology.

[65]  C. Jenkins,et al.  An update on the microbiology and epidemiology of enteropathogenic Escherichia coli in England 2010-2012. , 2013, Journal of medical microbiology.

[66]  B. Spur,et al.  Lipoxin A4 Increases Survival by Decreasing Systemic Inflammation and Bacterial Load in Sepsis , 2011, Shock.

[67]  C. Combescure,et al.  Environmental and T Cell–Intrinsic Factors Limit the Expansion of Neonatal Follicular T Helper Cells but May Be Circumvented by Specific Adjuvants , 2012, The Journal of Immunology.

[68]  M. Mathan,et al.  Morphology of rectal mucosa of patients with shigellosis. , 1991, Reviews of infectious diseases.

[69]  O. Ramilo,et al.  Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.

[70]  K. Schesser,et al.  Murine Neonates Infected with Yersinia enterocolitica Develop Rapid and Robust Proinflammatory Responses in Intestinal Lymphoid Tissues , 2013, Infection and Immunity.